Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Environmental Research|November 28, 2017
Unique pulmonary immunotoxicological effects of urban PM are not recapitulated solely by carbon black, diesel exhaust or coal fly ashNaina Gour, Kuladeep Sudini, Syed Muaz Khalil, et al.
Nature Immunology|August 31, 2010
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthmaStephane Lajoie, Ian P Lewkowich, Yusuke Suzuki, et al.
Mucosal Immunology|August 15, 2018
C3a is required for ILC2 function in allergic airway inflammationNaina Gour, Ursula Smole, Hwan-Mee Yong, et al.
Infection and Immunity|July 27, 2016
Role of Serum Amyloid A, Granulocyte-Macrophage Colony-Stimulating Factor, and Bone Marrow Granulocyte-Monocyte Precursor Expansion in Segmented Filamentous Bacterium-Mediated Protection from Entamoeba histolyticaStacey L Burgess, Mahmoud Saleh, Carrie A Cowardin, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
An Itch Receptor Drives MelanomaNaina Gour, Aishwarya Atakkatan, Moloud Akbarzadeh, et al.
European Journal of Immunology|January 30, 2015
Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthmaJaclyn W McAlees, Stephane Lajoie, Krista Dienger, et al.
The Journal of Allergy and Clinical Immunology|July 16, 2016
IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activationSara L Hall, Theresa Baker, Stephane Lajoie, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 26, 2025
Development of a preclinical model of ICU-associated sleep fragmentation and effects on pneumonia recovery in miceMahendra Damarla, Karthik Suresh, Linda Zheng, et al.
Nature Immunology|June 24, 2020
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunityUrsula Smole, Naina Gour, Jordan Phelan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2020
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical OutcomesAnju Singh, Anneleen Daemen, Dorothee Nickles, et al.
Pageof 3